DigiLab Moves Into Live and Stem-Cell Research Market with Launch of CellJet Arrayer | GenomeWeb

By Justin Petrone

Nearly four years after it acquired Harvard Bioscience's Genomic Solutions business, DigiLab is looking to parlay those microarray assets into the market for live cell arrays, and the stem cell-research market in particular.

Steve Blose, vice president of sales and marketing for the Holliston, Mass.-based firm, told BioArray News this week that the company is targeting cell researchers with its new CellJet cell array printer.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

The hashtag #stupidcommonnames is gaining fans among scientists who find the common names of some animals and plants dumb.

Fed up with budget slashes, job cuts, and muzzling mandates, researchers in Canada are making science a campaign issue in the upcoming elections.

A former NIH program officer says the Internet has blasted open the door for scientific publications more interested in dollars than quality research.

This Week in Science: New research into the emergence of infectious diseases, and scientists report on proteins involved in melanoma.